SUMMARY The incidence of Clostridium difficile cytotoxin has been studied in 69 consecutive patients with inflammatory bowel disease complicated by severe diarrhoea or ileostomy flux during 74 admissions to hospital. The cytotoxin was identified in only four patients, all of whom had received antimicrobials. Clostridium difficile, but not cytotoxin, was identified in 10 of 43 admissions. This followed antimicrobial prophylaxis to cover a recent operation in two patients, and five were on long-term sulphasalazine. Only three patients with Clostridium difficile had not received an antimicrobial within one month of the study. Isolation of Clostridium difficile alone is of doubtful pathological significance, as it spontaneously disappeared without treatment in all patients.
It has been suggested that Clostridium difficile toxin may be responsible for relapse in patients with inflammatory bowel disease.1 Clostridium difficile toxin has also been implicated in the pathogenesis of antibiotic associated colitis.3 4 The organism is not generally found in the faeces of healthy adults,5 but is present in 40%6 of normal neonates and the toxin is present in 14% of infants five months after birth. 7 Clostridium difficile without toxin may be recovered from patients exposed to a variety of antimicrobials without any' evidence of colitis and occasionally without diarrhoea.8 Many of the patients in whom Clostridium difficile has been identified during a relapse of inflammatory bowel disease' 2 were receiving maintenance sulphasalazine or systemic antibiotics. The purpose of this study has been to document the incidence of Clostridium difficile toxin in patients with acute diarrhoea or ileostomy flux complicating inflammatory bowel disease and to observe the natural history of Clostridium difficile in inflammatory bowel disease.
Methods

PATIENTS
All patients admitted to a single unit with symptomatic relapse of inflammatory bowel disease between November 1978 and August 1980 were studied. Relapse referred either to patients with severe systemic disease and acute diarrhoea leading to dehydration (irrespective of the site of disease or previous operation), or to patients with an ileostomy output greater than 1 litre per day. Sixty-nine patients were investigated during 74 hospital admissions ( Table 1 ). The reasons for admission included acute proctocolitis in 24, acute diarrhoea complicating small bowel Crohn's disease in 19, ileostomy flux in 10, and early postoperative diarrhoea or flux in 21. The underlying diagnosis included ulcerative colitis in 21. Crohn's disease was present in 48 patients three of whom also had an Table 2 .
Results (Table 2) One patient (no. 1) was admitted with a one-month history of diarrhoea; she had previously received co-trimoxazole and the appearances on sigmoidoscopy suggested acute proctocolitis. A biopsy confirmed pseudomembranous colitis (Table 3) and Clostridium difficile and cytotoxin were found.
Treatment with vancomycin eradicated the toxin and organism. The patient has had no further bowel symptoms during a follow-up of 18 months and we believe she was suffering from antibiotic associated colitis. This patients was excluded from subsequent analysis. Three patients (nos 2-4) acquired Clostridium difficile cytotoxin after an operation for
Crohn's disease and in each case they had received antimicrobial prophylaxis. Two of these patients were treated immediately with vancomycin with elimination of the toxin and a rapid clinical response. The third patient was discharged from hospital before the result of the cytotoxin test was known: the patient continued to have diarrhoea, repeat faecal samples revealed persistent excretion of Clostridium difficile, and subsequent treatment with vancomycin resulted in rapid clinical improvement and disappearance of the organism.
In 10 other patients, Clostridium difficile alone was recovered from the stool. Broth cultures of these clostridia all produced cytotoxin. Two patients (nos 5, 6) had been treated previously by total colectomy and ileorectal anastomosis and had received prophylactic antimicrobials. The eight remaining patients (nos 7-14) had been admitted with acute disease: four had acute ulcerative colitis, two had acute Crohi.'s colitis, and two had small intestinal Crohn's disease. Five of these patients, however, were receiving sulphasalazine for colitis, thus leaving only three who had not been recently exposed to an antibiotic. None of the patients with Clostridium difficile alone received specific therapy. All of the patients were re-investigated four to six weeks later, but in none was Clostridium difficile subsequently found in the stool. One of the patients, however, later developed a relapse of ulcerative colitis requiring colectomy. Although faecal cultures were negative for Clostridium difficile, the organism was identified from the submucosa of the resected colon.
Of the 54 patients with acute inflammatory bowel disease who had not received an antibiotic, other than sulphasalazine, within one month of the study, none had evidence of Clostridium difficile toxin. Thirty-one of these patients were studied during phase 1, and, of these, only eight (26%) had Clostridium difficile in their faeces. 
Discussion
This survey has shown that Clostridium difficile cytotoxin was identified in only four of the 74 episodes of severe diarrhoea complicating inflammatory bowel disease. This is in marked contrast with our experience in 88 patients with antibioticassociated colitis or diarrhoea, where cytotoxin was identified in 61 (69%) and where Clostridium difficile alone was recovered in all of the remaining 27 cases (31%).1o One patient in this study was subsequently shown to have had antibioticassociated colitis. The other three patients had undergone recent surgical treatment with antimicrobial prophylaxis. These patients did not differ clinically from many of the patients observed in this hospital who have had postoperative antibioticassociated colitis.9 None of the patients had a rectal biopsy during the episode of diarrhoea, principally because of their undeilying disease. Nevertheless, the manifestations of their disease and the rapid response to vancomycin"l suggests that these patients had had a mild episode of antibioticassociated colitis rather than intestinal colonisation by Clostridium difficile as a complication of their inflammatory disease. There were two other patients in whom the organism was recovered alone without cytotoxin after exposure to prophylactic antimicrobials given during colectomy and ileorectal anastomosis. The role of Clostridium difficile in causing the diarrhoea of these patients is uncertain. In our experience there are a small number of patients who have sigmoidoscopic or histological evidence of pseudomembranous colitis12 in whom the organism is found in the absence of cytotoxin13
and we believe that these two patients may have been in this category. Furthermore, in untreated patients the presence of toxin may be transient and often disappears despite persistent excretion of Clostridium difficile. It is possible that the absence of toxin might be due to insufficient numbers of clostridia to produce a measurable level of cytotoxin or to production of only small amounts of toxin by the clostridia. Clostridium difficile but not cytotoxin was found in single stool specimens from the remaining eight patients. This probably represents colonisation by the organism but our data do not establish whether this coincided with the onset of relapse, particularly as repeated stool specimens were not cultured. These patients had not had an operation or been exposed to antimicrobials other than sulphasalazine, which was being used as maintenance therapy for ulcerative colitis or Crohn's disease. 
